Mechanisms of B-cell lymphoma pathogenesis (original) (raw)

• Fisher, S. G. & Fisher, R. I. The epidemiology of non-Hodgkin's lymphoma. Oncogene 23, 6524–6534 (2004).
  Article CAS PubMed Google Scholar
• Jaffe, E. S., Harris, N. L., Stein, H. & Vardiman, J. W. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues (eds Kleihuis, P. & Sobin, L.) (IARC, Lyon, 2001).
  Google Scholar
• Rajewsky, K. Clonal selection and learning in the antibody system. Nature 381, 751–758 (1996).
  Article CAS PubMed Google Scholar
• Küppers, R., Klein, U., Hansmann, M. -L. & Rajewsky, K. Cellular origin of human B-cell lymphomas. N. Engl. J. Med. 341, 1520–1529 (1999).
  Article PubMed Google Scholar
• Stevenson, F. K. et al. The occurrence and significance of V gene mutations in B cell-derived human malignancy. Adv. Cancer Res. 83, 81–116 (2001).
  Article CAS PubMed Google Scholar
• Greaves, M. F. Differentiation-linked leukemogenesis in lymphocytes. Science 234, 697–704 (1986).
  Article CAS PubMed Google Scholar
• Shaffer, A. L., Rosenwald, A. & Staudt, L. M. Lymphoid malignancies: the dark side of B-cell differentiation. Nature Rev. Immunol. 2, 920–932 (2002).
  Article CAS Google Scholar
• Alizadeh, A. A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–511 (2000). Showed that distinct subsets of diffuse large B-cell lymphoma can be identifed by large-scale gene-expression profiling.
  Article CAS PubMed Google Scholar
• Klein, U. et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J. Exp. Med. 194, 1625–1638 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Küppers, R. & Dalla-Favera, R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20, 5580–5594 (2001).
  Article PubMed Google Scholar
• Willis, T. G. & Dyer, M. J. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood 96, 808–822 (2000).
  Article CAS PubMed Google Scholar
• Jäger, U. et al. Follicular lymphomas' BCL-2/IgH junctions contain templated nucleotide insertions: novel insights into the mechanism of t(14;18) translocation. Blood 95, 3520–3529 (2000).
  Article PubMed Google Scholar
• Tsujimoto, Y., Gorham, J., Cossman, J., Jaffe, E. & Croce, C. M. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229, 1390–1393 (1985).
  Article CAS PubMed Google Scholar
• Tsujimoto, Y., Louie, E., Bashir, M. M. & Croce, C. M. The reciprocal partners of both the t(14; 18) and the t(11; 14) translocations involved in B-cell neoplasms are rearranged by the same mechanism. Oncogene 2, 347–351 (1988).
  CAS PubMed Google Scholar
• Goossens, T., Klein, U. & Küppers, R. Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease. Proc. Natl Acad. Sci. USA 95, 2463–2468 (1998).
  CAS PubMed PubMed Central Google Scholar
• Bross, L. et al. DNA double-strand breaks in immunoglobulin genes undergoing somatic hypermutation. Immunity 13, 589–597 (2000).
  Article CAS PubMed Google Scholar
• Papavasiliou, F. N. & Schatz, D. G. Cell-cycle-regulated DNA double-stranded breaks in somatic hypermutation of immunoglobulin genes. Nature 408, 216–221 (2000).
  Article CAS PubMed Google Scholar
• Pasqualucci, L. et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412, 341–346 (2001). Showed that multiple proto-oncogenes are targeted by somatic hypermutation specifically in diffuse large B-cell lymphomas, which could have a major role in the pathogenesis of this lymphoma.
  Article CAS PubMed Google Scholar
• Raghavan, S. C., Swanson, P. C., Wu, X., Hsieh, C. L. & Lieber, M. R. A non-B-DNA structure at the Bcl-2 major breakpoint region is cleaved by the RAG complex. Nature 428, 88–93 (2004).
  Article CAS PubMed Google Scholar
• Hiom, K., Melek, M. & Gellert, M. DNA transposition by the RAG1 and RAG2 proteins: a possible source of oncogenic translocations. Cell 94, 463–470 (1998).
  Article CAS PubMed Google Scholar
• Roth, D. B. & Craig, N. L. VDJ recombination: a transposase goes to work. Cell 94, 411–414 (1998).
  Article CAS PubMed Google Scholar
• Müschen, M. et al. Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J. Exp. Med. 192, 1833–1840. (2000).
  Article PubMed PubMed Central Google Scholar
• Pasqualucci, L. et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc. Natl Acad. Sci. USA 95, 11816–11821 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Shen, H. M., Peters, A., Baron, B., Zhu, X. & Storb, U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280, 1750–1752 (1998).
  Article CAS PubMed Google Scholar
• Gronbaek, K. et al. Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood 92, 3018–3024 (1998).
  Article CAS PubMed Google Scholar
• Esser, C. & Radbruch, A. Immunoglobulin class switching: molecular and cellular analysis. Annu. Rev. Immunol. 8, 717–735 (1990).
  Article CAS PubMed Google Scholar
• Küppers, R. B cells under influence: transformation of B cells by Epstein–Barr virus. Nature Rev. Immunol 3, 801–812 (2003).
  Article CAS Google Scholar
• Rickinson, A. B. & Kieff, E. Epstein–Barr virus. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2575–2627 (Lippincott-Raven, Philadelphia, 2001).
  Google Scholar
• Thorley-Lawson, D. A. & Gross, A. Persistence of the Epstein–Barr virus and the origins of associated lymphomas. N. Engl. J. Med. 350, 1328–1337 (2004).
  Article CAS PubMed Google Scholar
• Young, L. S. & Rickinson, A. B. Epstein–Barr virus: 40 years on. Nature Rev. Cancer 4, 757–768 (2004).
  Article CAS Google Scholar
• Cannon, M. & Cesarman, E. Kaposi's sarcoma-associated herpes virus and acquired immunodeficiency syndrome-related malignancy. Semin. Oncol. 27, 409–419 (2000).
  CAS PubMed Google Scholar
• Guasparri, I., Keller, S. A. & Cesarman, E. KSHV vFLIP is essential for the survival of infected lymphoma cells. J. Exp. Med. 199, 993–1003 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Kraus, M., Alimzhanov, M. B., Rajewsky, N. & Rajewsky, K. Survival of resting mature B lymphocytes depends on BCR signaling via the Igα/β heterodimer. Cell 117, 787–800 (2004).
  Article CAS PubMed Google Scholar
• Lam, K. P., Kühn, R. & Rajewsky, K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90, 1073–1083 (1997). In references 33 and 34 mouse models were generated that provided strong evidence that normal mature B cells strictly depend on BCR expression and signalling for survival.
  Article CAS PubMed Google Scholar
• Gunven, P., Klein, G., Klein, E., Norin, T. & Singh, S. Surface immunoglobulins on Burkitt's lymphoma biopsy cells from 91 patients. Int. J. Cancer 25, 711–719 (1980).
  Article CAS PubMed Google Scholar
• Segal, G. H. et al. Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three-color immunocytometry. Cytometry 12, 350–359 (1991).
  Article CAS PubMed Google Scholar
• Yano, T. et al. Histogenetic correlations between subcategories of small noncleaved cell lymphomas. Blood 79, 1282–1290 (1992).
  Article CAS PubMed Google Scholar
• de Jong, D. et al. Translocation t(14;18) in B cell lymphomas as a cause for defective immunoglobulin production. J. Exp. Med. 169, 613–624 (1989).
  Article CAS PubMed Google Scholar
• Cleary, M. L. et al. Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma. Cell 44, 97–106 (1986).
  Article CAS PubMed Google Scholar
• Meeker, T. et al. Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies. N. Engl. J. Med. 312, 1658–1665 (1985).
  Article CAS PubMed Google Scholar
• Braeuninger, A. et al. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc. Natl Acad. Sci. USA 94, 9337–9342 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Chapman, C. J., Mockridge, C. I., Rowe, M., Rickinson, A. B. & Stevenson, F. K. Analysis of VH genes used by neoplastic B cells in endemic Burkitt's lymphoma shows somatic hypermutation and intraclonal heterogeneity. Blood 85, 2176–2181 (1995).
  Article CAS PubMed Google Scholar
• Lossos, I. S. et al. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc. Natl Acad. Sci. USA 97, 10209–10213 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Thompsett, A. R., Ellison, D. W., Stevenson, F. K. & Zhu, D. V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity. Blood 94, 1738–1746 (1999).
  Article CAS PubMed Google Scholar
• Klein, U. et al. Somatic hypermutation in normal and transformed human B cells. Immunol. Rev. 162, 261–280 (1998).
  Article CAS PubMed Google Scholar
• Kanzler, H., Küppers, R., Hansmann, M. L. & Rajewsky, K. Hodgkin and Reed–Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J. Exp. Med. 184, 1495–1505 (1996). This study provided the first evidence that the tumour cells in Hodgkin's lymphoma are derived from 'crippled', BCR-deficient GC B cells
  Article CAS PubMed Google Scholar
• Küppers, R. Molecular biology of Hodgkin's lymphoma. Adv. Cancer Res. 84, 277–312 (2002).
  Article PubMed Google Scholar
• Caldwell, R. G., Wilson, J. B., Anderson, S. J. & Longnecker, R. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9, 405–411 (1998).
  Article CAS PubMed Google Scholar
• Casola, S. et al. B cell receptor signal strength determines B cell fate. Nature Immunol. 5, 317–327 (2004). References 48 and 49 show that the EBV-encoded LMP2A can replace the function of the BCR in murine B cells.
  Article CAS Google Scholar
• Schwering, I. et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed–Sternberg cells of Hodgkin lymphoma. Blood 101, 1505–1512 (2003).
  Article CAS PubMed Google Scholar
• Engels, N. et al. Epstein–Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module. J. Exp. Med. 194, 255–264 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Merchant, M., Caldwell, R. G. & Longnecker, R. The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo. J. Virol. 74, 9115–9124 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Re, D. et al. Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells. Cancer Res. 61, 2080–2084 (2001).
  CAS PubMed Google Scholar
• Stein, H. et al. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 97, 496–501 (2001).
  Article CAS PubMed Google Scholar
• Bräuninger, A. et al. Epstein–Barr virus (EBV)-positive lymphoproliferations in posttransplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes. Eur. J. Immunol. 33, 1593–1602 (2003).
  Article PubMed CAS Google Scholar
• Capello, D. et al. Molecular histogenesis of posttransplant lymphoproliferative disorders. Blood 102, 3775–3785 (2003).
  Article CAS PubMed Google Scholar
• Timms, J. M. et al. Target cells of Epstein–Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma. Lancet 361, 217–223 (2003).
  Article PubMed Google Scholar
• Leithäuser, F., Bäuerle, M., Huynh, M. Q. & Möller, P. Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell lymphoma. Blood 98, 2762–2770 (2001).
  Article PubMed Google Scholar
• Pileri, S. A. et al. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. Am. J. Pathol. 162, 243–253 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Ritz, O. et al. Downregulation of internal enhancer activity contributes to abnormally low immunoglobulin expression in the MedB-1 mediastinal B-cell lymphoma cell line. J. Pathol. 205, 336–348 (2005).
  Article CAS PubMed Google Scholar
• Rosenwald, A. et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J. Exp. Med. 198, 851–862 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Savage, K. J. et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 102, 3871–3879 (2003).
  Article CAS PubMed Google Scholar
• Fais, F. et al. Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas. Leukemia 13, 1093–1099 (1999).
  Article CAS PubMed Google Scholar
• Gaidano, G. & Carbone, A. Primary effusion lymphoma: a liquid phase lymphoma of fluid-filled body cavities. Adv. Cancer Res. 80, 115–146 (2001).
  Article CAS PubMed Google Scholar
• Matolcsy, A., Nador, R. G., Cesarman, E. & Knowles, D. M. Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. Am. J. Pathol. 153, 1609–1614 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Arguello, M. et al. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines. Oncogene 22, 964–973 (2003).
  Article CAS PubMed Google Scholar
• Klein, U. et al. Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood 101, 4115–4121 (2003).
  Article CAS PubMed Google Scholar
• Daneshek, W. & Schwartz, R. S. Leukemia and auto-immunization- some possible relationships. Blood 14, 1151–1158 (1959).
  Article Google Scholar
• Borche, L., Lim, A., Binet, J. L. & Dighiero, G. Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood 76, 562–569 (1990).
  Article CAS PubMed Google Scholar
• Sthoeger, Z. M. et al. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J. Exp. Med. 169, 255–268 (1989).
  Article CAS PubMed Google Scholar
• Mann, D. L. et al. HTLV-I-associated B-cell CLL: indirect role for retrovirus in leukemogenesis. Science 236, 1103–1106 (1987).
  Article CAS PubMed Google Scholar
• Fais, F. et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J. Clin. Invest. 102, 1515–1525 (1998). References 72–75 show that B-CLL includes groups of cases with highly restricted BCR diversity, indicating a role of a set of common, restricted (auto)antigens in activating the lymphoma cells and/or their precursors.
  Article CAS PubMed PubMed Central Google Scholar
• Ghiotto, F. et al. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J. Clin. Invest. 113, 1008–1016 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Messmer, B. T. et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J. Exp. Med. 200, 519–525 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Tobin, G. et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vλ2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 101, 4952–4957 (2003).
  Article CAS PubMed Google Scholar
• Damle, R. N. et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 99, 4087–4093 (2002).
  Article CAS PubMed Google Scholar
• Montesinos-Rongen, M. et al. Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment. Am. J. Pathol. 155, 2077–2086 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Dighiero, G. et al. Autoantibody activity of immunoglobulins isolated from B-cell follicular lymphomas. Blood 78, 581–585 (1991).
  Article CAS PubMed Google Scholar
• Bahler, D. W. & Levy, R. Clonal evolution of a follicular lymphoma: evidence for antigen selection. Proc. Natl Acad. Sci. USA 89, 6770–6774 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Zhu, D. et al. Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood 99, 2562–2568 (2002).
  Article CAS PubMed Google Scholar
• Zhu, D., Ottensmeier, C. H., Du, M. Q., McCarthy, H. & Stevenson, F. K. Incidence of potential glycosylation sites in immunoglobulin variable regions distinguishes between subsets of Burkitt's lymphoma and mucosa-associated lymphoid tissue lymphoma. Br. J. Haematol. 120, 217–222 (2003).
  Article CAS PubMed Google Scholar
• Quinn, E. R. et al. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 98, 3745–3749 (2001).
  Article CAS PubMed Google Scholar
• Hermine, O. et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N. Engl. J. Med. 347, 89–94 (2002).
  Article CAS PubMed Google Scholar
• Wotherspoon, A. C. et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue after eradication of Helicobacter pylori. Lancet 342, 575–577 (1993).
  Article CAS PubMed Google Scholar
• Hussel, T., Isaacson, P. G., Crabtree, J. E. & Spencer, J. _Helicobacter pylori_-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J. Pathol. 178, 122–127 (1996). References 83–85 provide evidence that the growth of lymphoma cells might depend on chronic infection of the patients by bacteria or viruses.
  Article Google Scholar
• Greiner, A. et al. Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis. Lab. Invest. 70, 572–578 (1994).
  CAS PubMed Google Scholar
• Hussell, T., Isaacson, P. G., Crabtree, J. E., Dogan, A. & Spencer, J. Immunoglobulin specificity of low grade B cell gastrointestinal lymphoma of mucosa-associated lymphoid tissue (MALT) type. Am. J. Pathol. 142, 285–292 (1993).
  CAS PubMed PubMed Central Google Scholar
• Bende, R. J. et al. Immunoglobulins of B-cell non Hodgkin's lymphomas: musosa-associated lymphoid tissue lymphomas express a distinctive repertoire with frequent rheumatoid factor reactivity. J. Exp. Med. 201, (in the press).
• Dogan, A. et al. Follicular lymphomas contain a clonally linked but phenotypically distinct neoplastic B-cell population in the interfollicular zone. Blood 91, 4708–4714 (1998).
  Article CAS PubMed Google Scholar
• Johnson, P. W. et al. Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. Blood 82, 1848–1857 (1993).
  Article CAS PubMed Google Scholar
• Umetsu, D. T., Esserman, L., Donlon, T. A., DeKruyff, R. H. & Levy, R. Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones. J. Immunol. 144, 2550–2557 (1990).
  CAS PubMed Google Scholar
• Dave, S. S. et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N. Engl. J. Med. 351, 2159–2169 (2004).
  Article CAS PubMed Google Scholar
• Schmid, C. & Isaacson, P. G. Proliferation centres in B-cell malignant lymphoma, lymphocytic (B-CLL): an immunophenotypic study. Histopathol. 24, 445–451 (1994).
  Article CAS Google Scholar
• Buske, C. et al. Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand. Exp. Hematol. 25, 329–337 (1997).
  CAS PubMed Google Scholar
• Fluckiger, A. C. et al. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood 80, 3173–3181 (1992).
  Article CAS PubMed Google Scholar
• Ghia, P. et al. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22. Eur. J. Immunol. 32, 1403–1413 (2002).
  Article CAS PubMed Google Scholar
• van den Berg, A., Visser, L. & Poppema, S. High expression of the CC chemokine TARC in Reed–Sternberg cells. A possible explanation for the characteristic T-cell infiltration Hodgkin's lymphoma. Am. J. Pathol. 154, 1685–1691 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Ehrenfeld, M., Abu-Shakra, M., Buskila, D. & Shoenfeld, Y. The dual association between lymphoma and autoimmunity. Blood Cells Mol. Dis. 27, 750–756 (2001).
  Article CAS PubMed Google Scholar
• Straus, S. E. et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 98, 194–200. (2001).
  Article CAS PubMed Google Scholar
• Martin, T. et al. Salivary gland lymphomas in patients with Sjogren's syndrome may frequently develop from rheumatoid factor B cells. Arthritis Rheum. 43, 908–916 (2000).
  Article CAS PubMed Google Scholar
• Davis, R. E., Brown, K. D., Siebenlist, U. & Staudt, L. M. Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J. Exp. Med. 194, 1861–1874 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Küppers, R., Zhao, M., Hansmann, M. L. & Rajewsky, K. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J. 12, 4955–4967 (1993).
  Article PubMed PubMed Central Google Scholar
• MacLennan, I. C. Germinal centers. Annu. Rev. Immunol. 12, 117–139 (1994).
  Article CAS PubMed Google Scholar
• Liu, Y. J. et al. Sequential triggering of apoptosis, somatic mutation and isotype switch during germinal center development. Semin. Immunol. 8, 169–177 (1996).
  Article CAS PubMed Google Scholar
• Dogan, A. & Isaacson, P. G. Splenic marginal zone lymphoma. Semin. Diagn. Pathol. 20, 121–127 (2003).
  Article PubMed Google Scholar
• Chiorazzi, N. & Ferrarini, M. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu. Rev. Immunol. 21, 841–894 (2003).
  Article CAS PubMed Google Scholar
• Vaandrager, J. W. et al. Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization. Blood 88, 1177–1182 (1996).
  Article CAS PubMed Google Scholar
• Camacho, E. et al. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances. Blood 99, 238–244 (2002).
  Article CAS PubMed Google Scholar
• Schaffner, C., Idler, I., Stilgenbauer, S., Döhner, H. & Lichter, P. Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc. Natl Acad. Sci. USA 97, 2773–2778 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Cuneo, A. et al. 13q14 deletion in non-Hodgkin's lymphoma: correlation with clinicopathologic features. Haematologica. 84, 589–593 (1999).
  CAS PubMed Google Scholar
• Schaffner, C., Stilgenbauer, S., Rappold, G. A., Döhner, H. & Lichter, P. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Blood 94, 748–753 (1999).
  Article CAS PubMed Google Scholar
• Stankovic, T. et al. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet 353, 26–29 (1999).
  Article CAS PubMed Google Scholar
• Gaidano, G. et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 88, 5413–5417 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, Y. et al. 13q deletions in lymphoid malignancies. Blood 86, 1911–1915 (1995).
  Article CAS PubMed Google Scholar
• Baron, B. W. et al. Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas. Proc. Natl Acad. Sci. USA 90, 5262–5266 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Ye, B. H., Rao, P. H., Chaganti, R. S. & Dalla-Favera, R. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res. 53, 2732–2735 (1993).
  CAS PubMed Google Scholar
• Weiss, L. M., Warnke, R. A., Sklar, J. & Cleary, M. L. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N. Engl. J. Med. 317, 1185–1189 (1987).
  Article CAS PubMed Google Scholar
• Ladanyi, M., Offit, K., Jhanwar, S. C., Filippa, D. A. & Chaganti, R. S. MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas. Blood 77, 1057–1063 (1991).
  Article CAS PubMed Google Scholar
• Gronbaek, K. et al. ATM mutations are associated with inactivation of the ARF–TP53 tumor suppressor pathway in diffuse large B-cell lymphoma. Blood 100, 1430–1437 (2002).
  Article CAS PubMed Google Scholar
• Koduru, P. R. et al. Correlation between mutation in p53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma. Blood 90, 4078–4091 (1997).
  Article CAS PubMed Google Scholar
• Moller, M. B. et al. Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma. Leukemia 13, 453–459 (1999).
  Article CAS PubMed Google Scholar
• Melzner, I. et al. Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in MedB-1 mediastinal lymphoma line. Blood 105, 2535–2542 (2004).
  Article PubMed CAS Google Scholar
• Rossi, D. et al. Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma. Blood 104, A2268 (2004).
  Article Google Scholar
• Dalla-Favera, R., Martinotti, S., Gallo, R. C., Erikson, J. & Croce, C. M. Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science 219, 963–967 (1983).
  Article CAS PubMed Google Scholar
• Taub, R. et al. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc. Natl Acad. Sci. USA 79, 7837–7841 (1982).
  Article CAS PubMed PubMed Central Google Scholar
• Cinti, C. et al. Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes. Am. J. Pathol. 156, 751–760 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Cabannes, E., Khan, G., Aillet, F., Jarrett, R. F. & Hay, R. T. Mutations in the IκBα gene in Hodgkin's disease suggest a tumour suppressor role for IκBα. Oncogene 18, 3063–3070 (1999).
  Article CAS PubMed Google Scholar
• Krappmann, D. et al. Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed–Sternberg cells. Oncogene 18, 943–953 (1999).
  Article CAS PubMed Google Scholar
• Jungnickel, B. et al. Clonal deleterious mutations in the iκBα gene in the malignant cells in Hodgkin's disease. J. Exp. Med. 191, 395–401 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Emmerich, F. et al. Inactivating IκBε mutations in Hodgkin/Reed–Sternberg cells. J. Pathol. 201, 413–420 (2003).
  Article CAS PubMed Google Scholar
• Müschen, M. et al. Somatic mutations of the CD95 gene in Hodgkin and Reed-Sternberg cells. Cancer Res. 60, 5640–5643 (2000).
  PubMed Google Scholar
• Martin-Subero, J. I. et al. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood 99, 1474–1477 (2002).
  Article CAS PubMed Google Scholar
• Wlodarska, I. et al. Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma. Blood 101, 706–710 (2003).
  Article CAS PubMed Google Scholar
• Mateo, M. et al. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. Am. J. Pathol. 154, 1583–1589 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Dierlamm, J. et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 93, 3601–3609 (1999).
  Article CAS PubMed Google Scholar
• Willis, T. G. et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96, 35–45 (1999).
  Article CAS PubMed Google Scholar
• Zhang, Q. et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nature Genet. 22, 63–68 (1999).
  Article CAS PubMed Google Scholar
• Streubel, B. et al. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 101, 2335–2339 (2003).
  Article CAS PubMed Google Scholar
• Streubel, B., Vinatzer, U., Lamprecht, A., Raderer, M. & Chott, A. T(3;14)(p14. 1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 10 Feb 2005 (10.1038/sj.leu.2403644).
• Bertoni, F. et al. Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas. Leukemia 14, 446–448 (2000).
  Article CAS PubMed Google Scholar
• Seeberger, H. et al. Loss of Fas (CD95/APO-1) regulatory function is an important step in early MALT-type lymphoma development. Lab. Invest. 81, 977–986 (2001).
  Article CAS PubMed Google Scholar
• Iida, S. et al. The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood 88, 4110–4117 (1996).
  Article CAS PubMed Google Scholar
• Nador, R. G. et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 88, 645–656 (1996).
  Article CAS PubMed Google Scholar
• Avet-Loiseau, H. et al. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies. Cancer Res. 58, 5640–5645 (1998).
  CAS PubMed Google Scholar
• Chesi, M. et al. Frequent translocation t(4;14)(p16. 3;q32. 3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nature Genet. 16, 260–264 (1997).
  Article CAS PubMed Google Scholar
• Chesi, M. et al. Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood 91, 4457–4463 (1998).
  Article CAS PubMed Google Scholar
• Landowski, T. H., Qu, N., Buyuksal, I., Painter, J. S. & Dalton, W. S. Mutations in the Fas antigen in patients with multiple myeloma. Blood 90, 4266–4270 (1997).
  Article CAS PubMed Google Scholar
• Shou, Y. et al. Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma. Proc. Natl Acad. Sci. USA 97, 228–233 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, P. et al. Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial. Blood 88, 2699–2706 (1996).
  Article CAS PubMed Google Scholar
• Kuehl, W. M. & Bergsagel, P. L. Multiple myeloma: evolving genetic events and host interactions. Nature Rev. Cancer 2, 175–187 (2002).
  Article CAS Google Scholar